Novo Nordisk  

The Diabetes Consultation

Consultation infrastructure

Make available for consultations the following :

necessary members of the diabetes team

adequate time and adequate space

records and information for the individual with diabetes

means of communication to other health professionals involved in the individual's care
Consultation process
Include the following in any diabetes consultation :

Welcome
  1. Friendly greeting of the individual and early establishment of rapport

Problems review
  1. Understanding of any recent events disturbing the person's life-style
  2. Enquiry after general well-being and identification of new difficulties
  3. Review of self-monitored results, and discussion of their meaning
  4. Review of dietary behaviours and physical activity
  5. Review of diabetes education, skills, and foot care
  6. Review of insulin therapy and experience of hypoglycaemia
  7. Review of other medical conditions and therapy affecting diabetes
  8. Management of arterial risk factors identified at Annual Review
  9. Management of complications and other problems identified at Annual Review

Analysis and planning
  1. Summary of, and agreement on, main points covered in consultation
  2. Agreement on targets for future months
  3. Agreement on, and explanation of, changes in therapy
  4. Agreement on interval to next consultation

Recording
  1. Completion of a structured record / patient-held record of the consultation
Annual review
Include additionally, at Annual Review, surveillance of the following:
  1. Symptoms of ischaemic heart disease, peripheral vascular disease, neuropathy, impotence
  2. Feet including footwear, deformity or poor skin condition, ischaemia, ulceration, absent pulses, sensory impairment ( see Foot problems )
  3. Visual acuity
  4. Retinopathy by ophthalmoscopy / retinal photography ( see Eye damage )
  5. Kidney damage by albumin excretion and serum creatinine ( see Kidney damage )
  6. Hypertension ( see Kidney damage )
  7. Dyslipidaemia ( see Arterial risk factors )
  8. Injection sites
  9. Attendance at podiatry / ophthalmology / other if indicated

 

Organization of Clinical Monitoring

 

IDF Guidelines to Type 1 diabetes
Click here for 'Topic Finder'

Ensure effective delivery of care
Framework of Diabetes Care
The Diabetes Consultation
Organization of Clinical Monitoring
Monitoring Quality of Care
Click here for 'Promote effective self-care'
Click here for 'Control blood glucose, blood lipids, arterial factors'
Click here for 'Detect and manage diabetes complications'
Click here for 'Manage special problems'
Click here for 'Index'



Novo Nordisk Click here to return to the top of the page